All In Biotech

Drug Trial Radar · NCT06491914

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

A Phase 3b Single-Arm Study of Aflibercept 8 mg in Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Last checked: Nov 20, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,126

Actual

Start

Jul 24, 2024

Primary completion

Aug 26, 2025

Study completion Jan 7, 2027

Sponsor

Lead sponsor
Regeneron PharmaceuticalsRegeneron (REGN)
Sponsor type
Industry
First posted
Jul 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is researching aflibercept high dose (HD), referred to as "study drug", with an experimental dosing regimen. The study is focused on participants with nAMD and DME that have been previously treated with anti-vascular endothelial growth factor (anti-VEGF) medications. The aim of the study is to see how safe and effective aflibercept HD injections are when given as frequently as every 4 weeks. The study is also looking at what side effects may happen from taking the study drug.

Conditions

  • Neovascular Age-Related Macular Degeneration
  • Diabetic Macular Edema

Interventions

  • Aflibercept 8 mgDrug

    Administered by intravitreal (IVT) injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Participants With at Least One Treatment-emergent Adverse Event (TEAE)Time frame: Through week 24
  2. Participants With at Least One Serious TEAETime frame: Through week 24

Locations

54 sites in 2 countries. Site status is shown where the registry gives one.

  • Win Retina - Arcadia

    Arcadia, California

  • California Retina Consultants

    Bakersfield, California

  • Retina Specialists of Beverly Hills

    Beverly Hills, California

  • Salehi Retina Institute dba Retina Associates of Southern California

    Huntington Beach, California

  • South Coast Retina Center

    Long Beach, California

  • California Eye Specialists Medical Group, Inc.

    Pasadena, California

  • Retina Consultants of Southern California

    Redlands, California

  • Vrmg Inc

    Sacramento, California

  • Retina Consultants of Southern Colorado

    Colorado Springs, Colorado

  • Eye care Center of Northern Colorado doing business as Advanced Vision Research Institute

    Longmont, Colorado

  • Retina Group of New England

    Waterford, Connecticut

  • Advanced Research, LLC

    Deerfield Beach, Florida

  • Florida Retina Institute - Jacksonville

    Jacksonville, Florida

  • Florida Retina Consultants

    Lakeland, Florida

  • Florida Retina Institute - Orlando

    Orlando, Florida

  • Retina Speciality Institute - Pensacola, Florida

    Pensacola, Florida

  • Eye Associates of Pinellas

    Pinellas Park, Florida

  • Retina Vitreous Associates of Florida Saint Petersburg

    St. Petersburg, Florida

  • Retina Vitreous Associates of Florida

    Tampa, Florida

  • Center for Retina and Macular Disease

    Winter Haven, Florida

  • Georgia Retina

    Marietta, Georgia

  • Retina Consultants of Hawaii, Inc.

    ‘Aiea, Hawaii

  • University Retina and Macula Associates PC - Lemont

    Lemont, Illinois

  • Illinois Retina Associates

    Oak Park, Illinois

  • Cumberland Valley Retina Consultants-Ophthalmology

    Hagerstown, Maryland

  • Mid Atlantic Retina Specialists Hagerstown

    Hagerstown, Maryland

  • Opthalmic Consultants of Boston

    Boston, Massachusetts

  • Retina Consultants of Minnesota

    Edina, Minnesota

  • Deep Blue Retina Clinical Research PLLC

    Southaven, Mississippi

  • Vision Research Center Eye Associates of New Mexico

    Albuquerque, New Mexico

  • Vitreoretinal Consultants of NY - Westbury

    Westbury, New York

  • North Carolina Retina Associates

    Wake Forest, North Carolina

  • Retina Associates of Cleveland - Beachwood

    Beachwood, Ohio

  • Cincinnati Eye Institute

    Cincinnati, Ohio

  • Tulsa Retina Consultants

    Tulsa, Oklahoma

  • EyeHealth Northwest

    Portland, Oregon

  • Mid Atlantic Retina

    Bethlehem, Pennsylvania

  • Sewickley Eye Group

    Sewickley, Pennsylvania

  • Charleston Neuroscience Institute LLC

    Ladson, South Carolina

  • Palmetto Retina Center

    West Columbia, South Carolina

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.